RxDoctor Payments Data

Kayla Kimble, PA

Physician Assistant · Fayette, OHNPI 1811778343

Payments from drug & device makers

$1,108in general payments, 2019–2025

Across 48 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$250
  • Sanofi$105
  • Mylan Specialty L.p.$99
  • AbbVie$92
  • Regeneron Healthcare Solutions, Inc.$83
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • plus $398 from 14 others

What the payments were for

  • Food & beverage$1,108100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,108 in reported general payments places this provider in the 80th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$8,212
Medicare patients
70
Services billed
221

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$29,919
EliquisApixaban26$22,129
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$18,586
OzempicSemaglutide14$15,678
MounjaroTirzepatide13$13,636
FarxigaDapagliflozin Propanediol22$13,275
XareltoRivaroxaban12$10,338
JanuviaSitagliptin Phosphate11$5,449
Albuterol Sulfate HfaAlbuterol Sulfate56$2,201
Cyclobenzaprine Hcl38$856
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$682
Atorvastatin Calcium81$640
Lisinopril62$569
Amlodipine Besylate69$492
Mirtazapine17$484

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$250$31,86144 claims
Novo NordiskOzempic$22$15,67814 claims
Lilly USA, LLCMounjaro, Olanzapine$41$13,85926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Fayette

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →